Population
N- and C-terminal domain fragments of IGFBP4 and IGF1, and C-terminal domain fragment of IGFBP1
Design
Preclinical
Authors
Loading...
May guide IGFBP variant design for IGF inhibition; extends mechanistic insights but leaves open clinical translation.
The structural determination of IGFBP/IGF complexes reveals the mechanism of IGF signaling regulation, supporting the design of IGFBP variants as therapeutic IGF inhibitors.
Sitar et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: